Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool.

Autor: Kovacs N; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md; National Jewish Health, Denver, Colo., Benjamin K; ICON, Gaithersburg, Md., Holland-Thomas N; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Moshkovich O; ICON, Gaithersburg, Md., Nelsen LM; GlaxoSmithKline, Philadelphia, Pa., Ortega H; Gossamer Bio, Inc, San Diego, Calif., Schwartz EJ; ICON, Gaithersburg, Md., Steinfeld J; GlaxoSmithKline, Philadelphia, Pa., Kirby SY; GlaxoSmithKline, Research Triangle Park, NC., Klion A; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., Khoury P; Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md. Electronic address: khouryp@nih.gov.
Jazyk: angličtina
Zdroj: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2020 Oct; Vol. 8 (9), pp. 3209-3212.e8. Date of Electronic Publication: 2020 May 15.
DOI: 10.1016/j.jaip.2020.04.069
Databáze: MEDLINE